204 related articles for article (PubMed ID: 18077384)
1. Evasion of myofibroblasts from immune surveillance: a mechanism for tissue fibrosis.
Wallach-Dayan SB; Golan-Gerstl R; Breuer R
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20460-5. PubMed ID: 18077384
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: FasL(+) immune cells promote resolution of fibrosis.
Wallach-Dayan SB; Elkayam L; Golan-Gerstl R; Konikov J; Zisman P; Dayan MR; Arish N; Breuer R
J Autoimmun; 2015 May; 59():67-76. PubMed ID: 25812467
[TBL] [Abstract][Full Text] [Related]
3. Epithelial cell apoptosis by fas ligand-positive myofibroblasts in lung fibrosis.
Golan-Gerstl R; Wallach-Dayan SB; Amir G; Breuer R
Am J Respir Cell Mol Biol; 2007 Mar; 36(3):270-5. PubMed ID: 16990614
[TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts.
Nareznoi D; Konikov-Rozenman J; Petukhov D; Breuer R; Wallach-Dayan SB
Cells; 2020 Feb; 9(2):. PubMed ID: 32053892
[TBL] [Abstract][Full Text] [Related]
5. Cellular FLICE-like inhibitory protein deviates myofibroblast fas-induced apoptosis toward proliferation during lung fibrosis.
Golan-Gerstl R; Wallach-Dayan SB; Zisman P; Cardoso WV; Goldstein RH; Breuer R
Am J Respir Cell Mol Biol; 2012 Sep; 47(3):271-9. PubMed ID: 22582174
[TBL] [Abstract][Full Text] [Related]
6. Thy-1 interaction with Fas in lipid rafts regulates fibroblast apoptosis and lung injury resolution.
Liu X; Wong SS; Taype CA; Kim J; Shentu TP; Espinoza CR; Finley JC; Bradley JE; Head BP; Patel HH; Mah EJ; Hagood JS
Lab Invest; 2017 Mar; 97(3):256-267. PubMed ID: 28165468
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.
Omokaro SO; Desierto MJ; Eckhaus MA; Ellison FM; Chen J; Young NS
J Immunol; 2009 Mar; 182(6):3414-22. PubMed ID: 19265119
[TBL] [Abstract][Full Text] [Related]
8. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
Huang G; Nishimoto K; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
[TBL] [Abstract][Full Text] [Related]
9. Fas- and FasL-deficient mice are resistant to the induction of bleomycin-induced scleroderma.
Yamamoto T; Yokozeki H; Nishioka K
Arch Dermatol Res; 2007 Feb; 298(9):465-8. PubMed ID: 17102953
[TBL] [Abstract][Full Text] [Related]
10. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
O' Reilly LA; Tai L; Lee L; Kruse EA; Grabow S; Fairlie WD; Haynes NM; Tarlinton DM; Zhang JG; Belz GT; Smyth MJ; Bouillet P; Robb L; Strasser A
Nature; 2009 Oct; 461(7264):659-63. PubMed ID: 19794494
[TBL] [Abstract][Full Text] [Related]
11. HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
Krzyzowska M; Baska P; Orlowski P; Zdanowski R; Winnicka A; Eriksson K; Stankiewicz W
PLoS One; 2013; 8(7):e70308. PubMed ID: 23922974
[TBL] [Abstract][Full Text] [Related]
12. The involvement of Fas-Fas ligand pathway in fibrosing lung diseases.
Kuwano K; Miyazaki H; Hagimoto N; Kawasaki M; Fujita M; Kunitake R; Kaneko Y; Hara N
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):53-60. PubMed ID: 9870917
[TBL] [Abstract][Full Text] [Related]
13. E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL.
Mustafa N; Mitxelena J; Infante A; Zenarruzabeitia O; Eriz A; Iglesias-Ara A; Zubiaga AM
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008734
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
Im J; Kim K; Hergert P; Nho RS
J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
[TBL] [Abstract][Full Text] [Related]
15. Fas- or FasL-deficient mice display an increased sensitivity to nitrobenzene-induced testicular germ cell apoptosis.
Richburg JH; Nañez A
Toxicol Lett; 2003 Mar; 139(1):1-10. PubMed ID: 12595153
[TBL] [Abstract][Full Text] [Related]
16. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis.
Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW
JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280
[TBL] [Abstract][Full Text] [Related]
17. The Fas/Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice.
Aoshiba K; Yasui S; Tamaoki J; Nagai A
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):695-700. PubMed ID: 10934108
[TBL] [Abstract][Full Text] [Related]
18. Bleomycin-Treated Chimeric Thy1-Deficient Mice with Thy1-Deficient Myofibroblasts and Thy-Positive Lymphocytes Resolve Inflammation without Affecting the Fibrotic Response.
Cohen PY; Breuer R; Zisman P; Wallach-Dayan SB
Mediators Inflamm; 2015; 2015():942179. PubMed ID: 26300593
[TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis.
Sisson TH; Ajayi IO; Subbotina N; Dodi AE; Rodansky ES; Chibucos LN; Kim KK; Keshamouni VG; White ES; Zhou Y; Higgins PD; Larsen SD; Neubig RR; Horowitz JC
Am J Pathol; 2015 Apr; 185(4):969-86. PubMed ID: 25681733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
